Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: China-US Trade Talks Positive But Lower Call

Mon, 18th Nov 2019 07:42

(Alliance News) - Stock prices in London were set to open marginally lower on Monday, with investors unmoved by the latest hints US and China trade reconciliation, and amid uncertainty about US President Donald Trump's policy on auto-part imports from the European Union.

IG futures indicate the FTSE 100 index is to open 3.0 points lower at 7,300.3. The blue-chip index closed up 10.18 points, or 0.1%, on Friday at 7,302.94, ending the week down 0.8%.

"European stocks are expected to kick off a new week a little flat on Monday, with more talks between the US and China failing to excite investors in the way they have been recently," OANDA market analyst Craig Erlam said.

Top Chinese and US trade negotiators held "constructive" discussions over the phone on a preliminary trade deal between the two countries, China's commerce ministry announced in a statement on Sunday.

The long-running trade war between Washington and Beijing has weighed on the global economy and spooked markets, with the two sides imposing punitive tariffs on hundreds of billions of dollars in two-way trade.

US President Trump announced a "phase one" trade deal last month which has yet to be signed.

Vice Premier Liu He spoke with US Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin on Saturday, and had "constructive discussion on each side's core concerns regarding the phase-one agreement", the Chinese commerce ministry said.

The two sides will "continue to maintain close communication", it added, without providing further details.

The Japanese Nikkei 225 index closed 0.5% higher on Monday. In China, the Shanghai Composite ended up 0.6%, while the Hang Seng index in Hong Kong is up 1.3%.

In the US on Friday, stocks ended in the green, the Dow Jones Industrial Average and S&P 500 both 0.8% higher and the Nasdaq Composite up 0.7%.

Last week, a combative US president hit out at the trading bloc, labelling the European Union's barriers "very, very difficult".

According to AFP, the delay on a decision on whether to slap tariffs on auto parts imported from the European Union could last for another six months.

"Donald Trump hasn't made a decision in relation to EU auto tariffs, and that is acting as a cap to eurozone equity benchmarks. The chatter last week was the US leader would defer the decision to impose tariffs by six months. Trump might be saving the EU economic war for his campaign trail next year," CMC Markets analyst David Madden commented.

In the FTSE 100, accounting software firm Sage Group said it will secure GBP232 million from the sale of a subsidiary to global payments company Elavon.

The disposal of Sage Pay, which generated revenue of GBP41 million last year, is subject to Elavon securing approval from US regulators.

Technical products and services firm Diploma reported full-year revenue growth of 12% to GBP544.7 million.

The FTSE 250 firm's pretax profit stretched 15% year-on-year to GBP83.5 million, and Diploma upped its full-year dividend to 29.0 pence per share from 25.5p.

Looking ahead, Diploma said: "Despite the uncertain political and economic environment impacting industrial markets, the board remains confident of further progress in the current financial year as moderately lower underlying growth will be offset by a strong contribution from acquisitions."

Diploma spent GBP78.3 million, a record investment, on acquisitions in the year ended September 30.

M&A activity continued on Monday, following a busy day for the London market on Friday, which saw Amerisur Resources, Carpetright and Eddie Stobart Logistics all agreeing to purchases.

On Monday, Consort Medical was subject to a takeover bid from a subsidiary of Swedish pharmaceutical firm Recipharm AB.

Recipharm will acquire the London-listed medical devices maker for GBP505 million, paying 1,010p for each Consort share, about a 40% premium. The deal gives the company an enterprise value of GBP627 million, including debt.

In the US, the National Association of Home Builders' housing market index for November is published at 1400 GMT.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
11 Sep 2019 09:31

BROKER RATINGS SUMMARY: HSBC Downgrades Shell To Hold From Buy

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:----------FTSE 100----------HSBC CUTS ROYAL DUTCH SHELL TO - BP

Read more
11 Sep 2019 09:23

UPDATE 1-London's FTSE 100 gains on hopes of stimulus, trade resolution

* FTSE 100 up 0.6%, FTSE 250 up 0.7%* Financials, miners lead gains* GMS drops after delaying results (Adds company news items, analyst comment, updates share moves)By Muvija M and Shashwat AwasthiSept 11 (Reuters) - UK blue-chips edged higher on We...

Read more
4 Sep 2019 16:09

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 5 SeptemberAvanti Communications (re delisting)FIH GroupCarpetrightMyanmar 6

Read more
16 Jul 2019 16:53

Polar Capital Builds Over 7% Stake In Consort Medical

(Alliance News) - Consort Medical PLC on Tuesday said Polar Capital LLP now holds a 7.4% interest in the drug manufacturing technology provider.Prior to this transaction on Monday, Polar if

Read more
15 Jul 2019 10:08

Consort Medical Warns Of Financial Impact Following Incident

(Alliance News) - Medical devices maker Consort Medical PLC on Monday warned of a hit to annual profit due to an explosion at a facility.The incident was at Consort's Cramlington in The

Read more
13 Jun 2019 10:50

Consort Medical Confident On Wixela Progress As Profit Declines

(Alliance News) - Consort Medical PLC on Thursday reported a "solid" annual performance, despite a 28% drop in profit.Drug and delivery device maker Consort reported pretax profit

Read more
6 Jun 2019 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 7 June Seneca Global Income & Growth TrustFull Year ResultsMonday 10 traffic 11

Read more
10 May 2019 09:36

Polar Capital Global Healthcare Lags Behind Benchmark In First Half

LONDON (Alliance News) - Polar Capital Global Healthcare Trust PLC said on Friday it lagged against its benchmark for the first half of its financial year, as the healthcare trust underperformed a

Read more
7 Feb 2019 14:38

Nicholson Exits Consort Medical Remuneration Committee On AGM Concerns

LONDON (Alliance News) - Consort Medical PLC on Thursday said Ian Nicholson has stepped down from its remuneration committee in order to satisfy shareholder concerns.At its annual general a

Read more
21 Jan 2019 09:36

BROKER RATINGS SUMMARY: Goldman Cuts Rentokil, Experian; Lifts Babcock

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday afternoon and Monday morning:----------FTSE 100----------GOLDMAN CUTS TO - -

Read more
20 Jan 2019 16:33

Sunday share tips: Consort Medical, Weir Group

(Sharecast News) - In her 'Inside the City' column for the Sunday Times, Sabah Meddings ws looking at pharmaceuticals firm Consort, and how the ongoing government shutdown in the US was affecting its portfolio.

Read more
4 Dec 2018 10:45

Consort Medical Expects Wixela Delay To Hurt Profit, Shares Plunge

LONDON (Alliance News) - Shares in Consort Medical PLC fell early Tuesday after the drug delivery company warned that delays to Mylan NV's Wixela inhaler for lung disease treatment will hit in

Read more
4 Dec 2018 10:36

Consort Medical to take £3m hit from delays to Mylan's Wixela inhaler

(Sharecast News) - Drug and delivery device company Consort Medical was under the cosh on Tuesday as it warned that pre-tax profit for the current financial year will take a £3m hit from delays to its generic Advair programme.

Read more
27 Nov 2018 16:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 28 November RPC GroupHalf Year ResultsTen LifestyleFull Year Year Year Year the

Read more
6 Nov 2018 09:16

Consort Appoints Former AstraZeneca Executive As Chairman Designate

LONDON (Alliance News) - Drug delivery devices manufacturer Consort Medical PLC said Tuesday it has appointed Chris Brinsmead as non-executive director and chairman designate of the will join the

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.